|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1103710838 |
003 |
OCoLC |
005 |
20231120010356.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
190606t20192019enk ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d EBLCP
|d OPELS
|d OCLCF
|d UKMGB
|d UKAHL
|d OCLCQ
|d UPM
|d YDX
|d ERF
|d LVT
|d SFB
|d OCLCO
|d NLW
|d OCLCQ
|d OCLCO
|d COM
|d OCLCQ
|d OCLCO
|
015 |
|
|
|a GBB9B1741
|2 bnb
|
016 |
7 |
|
|a 019436638
|2 Uk
|
019 |
|
|
|a 1229725159
|
020 |
|
|
|a 9780128142943
|q (electronic bk.)
|
020 |
|
|
|a 0128142944
|q (electronic bk.)
|
020 |
|
|
|a 0128142936
|
020 |
|
|
|a 9780128142936
|
020 |
|
|
|z 9780128142936
|
035 |
|
|
|a (OCoLC)1103710838
|z (OCoLC)1229725159
|
050 |
|
4 |
|a HD9665.5
|
072 |
|
7 |
|a BUS
|x 070000
|2 bisacsh
|
072 |
|
7 |
|a MMG
|2 bicssc
|
072 |
|
7 |
|a TCB
|2 bicssc
|
082 |
0 |
4 |
|a 338.476151
|2 23
|
100 |
1 |
|
|a S�anchez-Serrano, Ibis,
|e author.
|
245 |
1 |
4 |
|a The core model :
|b a collaborative paradigm for the pharmaceutical industry and global health care /
|c Ibis S�anchez-Serrano.
|
264 |
|
1 |
|a London :
|b Academic Press, an imprint of Elsevier,
|c [2019]
|
264 |
|
4 |
|c �2019
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed June 7, 2019).
|
520 |
|
|
|a The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care develops the innovative core model, an organizational research and design paradigm and economic theory that proposes a collaborative approach to resolving global health issues and improving the productivity of drug development. The model proposes that scientific collaboration does not occur in an unstructured manner, but actually takes place within a highly structured order where knowledge is transferred, integrated and finally translated into commercial products. An understanding of this model will help solve the global pharmaceutical industry�s productivity problems and address important global health care and economic issues. This book is useful to researchers, advanced students, regulators, and management in pharmaceutical industries, as well as healthcare professionals, those working in health economics, and those interested in scientific innovation processes.
|
505 |
0 |
|
|a 1. Introduction: The Core Model; 2. The "Core"; 3. "The Bridge"; 4. "The Periphery"; 5. The Core Model and Intellectual Property and Financial Interests; 6. The Core Model and The Pharmaceutical Industry Productivity Crisis; 7. The Core Model, Innovation, Economic Growth and Development and Policy-Making; 8. The Core Model and Global Health Care; 9. Conclusion The Core Model: A Novel Economic Theory
|
650 |
|
0 |
|a Pharmaceutical industry.
|
650 |
|
0 |
|a Medical care.
|
650 |
|
0 |
|a World health.
|
650 |
1 |
2 |
|a Drug Industry
|x economics
|0 (DNLM)D004345Q000191
|
650 |
1 |
2 |
|a Global Health
|x economics
|0 (DNLM)D014943Q000191
|
650 |
2 |
2 |
|a Drug Development
|x economics
|0 (DNLM)D000076722Q000191
|
650 |
|
2 |
|a Drug Industry
|0 (DNLM)D004345
|
650 |
|
2 |
|a Global Health
|0 (DNLM)D014943
|
650 |
|
2 |
|a Patient Care
|0 (DNLM)D005791
|
650 |
|
6 |
|a Industrie pharmaceutique.
|0 (CaQQLa)201-0042410
|
650 |
|
6 |
|a Sant�e mondiale.
|0 (CaQQLa)201-0037312
|
650 |
|
6 |
|a Soins m�edicaux.
|0 (CaQQLa)201-0052619
|
650 |
|
7 |
|a BUSINESS & ECONOMICS
|x Industries
|x General.
|2 bisacsh
|
650 |
|
7 |
|a Medical care
|2 fast
|0 (OCoLC)fst01013753
|
650 |
|
7 |
|a Pharmaceutical industry
|2 fast
|0 (OCoLC)fst01060129
|
650 |
|
7 |
|a World health
|2 fast
|0 (OCoLC)fst01181338
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128142936
|z Texto completo
|